Display options
Cite
Ghanemi A. Psychiatric neural networks and neuropharmacology: Selected advances and novel implications. Saudi Pharm J. 2013;22(2):95-100doi: 10.1016/j.jsps.2013.01.008.
Ghanemi, A. (2014). Psychiatric neural networks and neuropharmacology: Selected advances and novel implications. Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society, 22(2), 95-100. https://doi.org/10.1016/j.jsps.2013.01.008
Ghanemi, Abdelaziz. "Psychiatric neural networks and neuropharmacology: Selected advances and novel implications." Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society vol. 22,2 (2014): 95-100. doi: https://doi.org/10.1016/j.jsps.2013.01.008
Ghanemi A. Psychiatric neural networks and neuropharmacology: Selected advances and novel implications. Saudi Pharm J. 2014 Apr;22(2):95-100. doi: 10.1016/j.jsps.2013.01.008. Epub 2013 Feb 10. PMID: 24648819; PMCID: PMC3950528.
Copy Download .nbib Format: NLM
Share it on

Saudi Pharm J. 2014 Apr;22(2):95-100. doi: 10.1016/j.jsps.2013.01.008. Epub 2013 Feb 10.

Psychiatric neural networks and neuropharmacology: Selected advances and novel implications.

Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society

Abdelaziz Ghanemi

Affiliations

  1. Department of Pharmacology, China Pharmaceutical University, Nanjing 210009, China.

PMID: 24648819 PMCID: PMC3950528 DOI: 10.1016/j.jsps.2013.01.008

Abstract

Psychiatric disorders are often considered as simple imbalances between a limited number of cerebral neurotransmitters. In fact, it is more complicated than this "simple approach" and each psychiatric disorder constitutes network dysfunction within which several agents and factors are implicated. Thus, the therapeutical perspectives and implications are as vast and as numerous as the diversity of those network dysfunctions. Furthermore, the description of factors influencing diseases prognoses and treatment efficacy indicates new elements to consider both in therapies and drug researches.

Keywords: Neural networks; Potential target; Psychiatry; Therapeutical implication

References

  1. Psychopharmacology (Berl). 1989;98(2):203-6 - PubMed
  2. Brain Res. 2000 Dec 15;886(1-2):172-189 - PubMed
  3. Pharmacol Biochem Behav. 1991 Jun;39(2):469-72 - PubMed
  4. Arch Gen Psychiatry. 2006 Mar;63(3):332-9 - PubMed
  5. J Neurochem. 1989 Oct;53(4):1077-82 - PubMed
  6. Pediatrics. 2002 May;109(5):721-7 - PubMed
  7. Nat Rev Neurosci. 2009 Jun;10(6):423-33 - PubMed
  8. Neuropharmacology. 2012 Jan;62(1):125-34 - PubMed
  9. Neurosci Biobehav Rev. 2008 Sep;32(7):1293-314 - PubMed
  10. Neuropharmacology. 2012 Jan;62(1):13-20 - PubMed
  11. Proc Natl Acad Sci U S A. 1992 Mar 15;89(6):2046-50 - PubMed
  12. J Neurosci. 2000 Dec 15;20(24):9104-10 - PubMed
  13. Curr Psychiatry Rep. 2006 Dec;8(6):452-7 - PubMed
  14. J Neurosci. 1992 Sep;12(9):3642-50 - PubMed
  15. Int J Dev Neurosci. 2007 Oct;25(6):341-7 - PubMed
  16. J Clin Psychiatry. 2000;61 Suppl 6:4-6 - PubMed
  17. Psychopharmacology (Berl). 1995 Sep;121(1):1-26 - PubMed
  18. J Neurosci. 2006 Mar 8;26(10):2788-97 - PubMed
  19. Eur J Pharmacol. 2002 Oct 4;452(2):163-73 - PubMed
  20. CNS Neurol Disord Drug Targets. 2009 Dec;8(6):451-8 - PubMed
  21. Brain Res. 2010 Feb 16;1314:44-55 - PubMed
  22. Neuroimage. 2012 Jan 2;59(1):218-26 - PubMed
  23. Biol Psychiatry. 2006 Jun 15;59(12):1151-9 - PubMed
  24. J Pharmacol Exp Ther. 2007 Dec;323(3):838-45 - PubMed
  25. J Neurochem. 1989 Nov;53(5):1629-35 - PubMed
  26. Eur Psychiatry. 2002 Jul;17 Suppl 3:300-5 - PubMed
  27. Curr Pharm Des. 2009;15(14):1563-86 - PubMed
  28. J Neurosci. 1999 Dec 1;19(23):10494-501 - PubMed
  29. Prog Brain Res. 2008;167:171-86 - PubMed
  30. Psychopharmacology (Berl). 2009 Sep;205(4):565-75 - PubMed
  31. Psychopharmacology (Berl). 2001 Sep;157(2):151-62 - PubMed
  32. CNS Drug Rev. 2003 Summer;9(2):187-98 - PubMed
  33. Dialogues Clin Neurosci. 2008;10(4):385-400 - PubMed
  34. Neuropharmacology. 2012 Jan;62(1):21-34 - PubMed
  35. JAMA. 2007 Apr 18;297(15):1683-96 - PubMed
  36. Arch Gen Psychiatry. 2006 Aug;63(8):898-906 - PubMed
  37. Psychopharmacology (Berl). 2010 Jun;210(2):285-94 - PubMed
  38. Neuropsychopharmacology. 1998 Mar;18(3):135-74 - PubMed
  39. J Clin Psychopharmacol. 1995 Feb;15(1):49-57 - PubMed
  40. Psychopharmacology (Berl). 2002 Jul;162(3):255-64 - PubMed
  41. Rev Neurosci. 2008;19(6):395-411 - PubMed
  42. Psychopharmacology (Berl). 2005 Nov;183(1):118-26 - PubMed
  43. BMJ. 2004 Feb 28;328(7438):524-5 - PubMed
  44. Proc Natl Acad Sci U S A. 1988 Jul;85(14):5274-8 - PubMed
  45. Science. 2003 Jul 18;301(5631):386-9 - PubMed
  46. CNS Drugs. 2009;23(6):493-509 - PubMed
  47. Neurosci Biobehav Rev. 2003 Jan-Mar;27(1-2):3-18 - PubMed
  48. J Neurosci. 2008 Jan 9;28(2):407-14 - PubMed
  49. J Pharmacol Exp Ther. 2001 Oct;299(1):147-58 - PubMed
  50. Int J Neuropsychopharmacol. 2008 Mar;11(2):243-7 - PubMed
  51. Arch Gen Psychiatry. 2007 Mar;64(3):327-37 - PubMed
  52. Pharmacol Biochem Behav. 2012 Jan;100(3):431-9 - PubMed
  53. Trends Neurosci. 1995 Feb;18(2):69-70 - PubMed
  54. Psychiatry Res. 1993 Jun;47(3):267-80 - PubMed
  55. Pharmacopsychiatry. 2005 Jan;38(1):1-5 - PubMed
  56. Neuroscience. 1999;89(4):999-1002 - PubMed
  57. Pharmacol Biochem Behav. 2012 Jan;100(3):419-24 - PubMed
  58. Neuropharmacology. 2012 Jan;62(1):115-24 - PubMed
  59. Proc Natl Acad Sci U S A. 2009 Oct 27;106(43):18396-401 - PubMed
  60. Trends Pharmacol Sci. 2003 Apr;24(4):198-205 - PubMed
  61. J Neuroendocrinol. 2007 Mar;19(3):213-26 - PubMed
  62. Res Commun Chem Pathol Pharmacol. 1992 Nov;78(2):193-210 - PubMed
  63. Behav Brain Res. 2012 Jan 1;226(1):293-300 - PubMed
  64. Science. 1987 Sep 4;237(4819):1219-23 - PubMed
  65. Neuropharmacology. 2012 Jan;62(1):167-76 - PubMed
  66. Neuropsychopharmacology. 2008 Feb;33(3):643-52 - PubMed
  67. Psychopharmacology (Berl). 2004 Apr;172(4):463-70 - PubMed
  68. Drug Alcohol Depend. 1998 Jun-Jul;51(1-2):23-47 - PubMed
  69. Can J Psychiatry. 2007 Sep;52(9):553-62 - PubMed
  70. J Neurosci. 2001 Sep 15;21(18):7397-403 - PubMed
  71. J Neurosci. 2002 Dec 15;22(24):10883-90 - PubMed
  72. Eur Neuropsychopharmacol. 2006 Feb;16(2):79-83 - PubMed
  73. J Clin Psychopharmacol. 1997 Apr;17 Suppl 1:2S-18S - PubMed
  74. J Clin Psychopharmacol. 2002 Dec;22(6):568-75 - PubMed
  75. J Neurosci. 2003 Jul 2;23(13):5674-83 - PubMed
  76. Pharmacol Ther. 2009 Sep;123(3):334-43 - PubMed
  77. Pharmacol Ther. 2007 Nov;116(2):306-21 - PubMed
  78. PLoS One. 2011 Jan 31;6(1):e16646 - PubMed
  79. Arch Gen Psychiatry. 2000 Oct;57(10):925-35 - PubMed
  80. Drug Saf. 1998 Jan;18(1):57-82 - PubMed
  81. J Pharmacol Exp Ther. 2003 Apr;305(1):323-30 - PubMed
  82. Annu Rev Neurosci. 2000;23:155-84 - PubMed
  83. Biochim Biophys Acta. 2007 Apr;1768(4):976-93 - PubMed
  84. Neuropsychopharmacology. 2002 Dec;27(6):949-59 - PubMed
  85. Am J Psychiatry. 2010 Nov;167(11):1305-20 - PubMed
  86. Neuropharmacology. 2012 Jan;62(1):474-84 - PubMed
  87. J Neurosci. 1992 Feb;12(2):483-8 - PubMed
  88. Psychol Rev. 1987 Oct;94(4):469-92 - PubMed
  89. Nat Neurosci. 2007 Sep;10(9):1116-24 - PubMed
  90. Science. 1986 Aug 15;233(4765):774-6 - PubMed

Publication Types